This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1995;32(6):397-404.

doi: 10.3109/02770909409077750.

Long-acting inhaled beta agonists

S A Tilles¹, H S Nelson

Affiliations

PMID: 7592242
DOI: 10.3109/02770909409077750

Review

Long-acting inhaled beta agonists

S A Tilles et al. J Asthma. 1995.

. 1995;32(6):397-404.

doi: 10.3109/02770909409077750.

Authors

S A Tilles¹, H S Nelson

Affiliation

¹ National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206, USA.

PMID: 7592242
DOI: 10.3109/02770909409077750

No abstract available

PubMed Disclaimer

Comment in

Long-acting inhaled beta agonists in the treatment of bronchial asthma.
Wellman JJ. Wellman JJ. J Asthma. 1995;32(6):395-6. doi: 10.3109/02770909409077749. J Asthma. 1995. PMID: 7592241 No abstract available.

Similar articles

An update on the safety of long-acting beta-agonists in asthma patients using inhaled corticosteroids.
Salpeter SR. Salpeter SR. Expert Opin Drug Saf. 2010 May;9(3):407-19. doi: 10.1517/14740330903535852. Expert Opin Drug Saf. 2010. PMID: 20408768 Review.
Deleterious effects of inhaled beta-agonists: short-acting and long-acting agents differ.
Sears MR. Sears MR. Chest. 2001 May;119(5):1297-9. doi: 10.1378/chest.119.5.1297. Chest. 2001. PMID: 11348928 No abstract available.
A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
Sovani MP, Whale CI, Tattersfield AE. Sovani MP, et al. Drug Saf. 2004;27(10):689-715. doi: 10.2165/00002018-200427100-00001. Drug Saf. 2004. PMID: 15350154 Review.
Long acting inhaled beta 2 agonists and inhaled anticholinergic drugs: benefits and side effects in childhood asthma.
Naspitz CK. Naspitz CK. Pediatr Pulmonol Suppl. 1997;16:96-7. doi: 10.1002/ppul.1950230855. Pediatr Pulmonol Suppl. 1997. PMID: 9443223 Review. No abstract available.
[Interaction between inhaled corticosteroids and long-acting beta-2-agonists].
Kardos P. Kardos P. Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S386-9. doi: 10.1055/s-0029-1243047. Epub 2009 Nov 25. Dtsch Med Wochenschr. 2009. PMID: 19941242 Review. German. No abstract available.

See all similar articles

Cited by

Clinical pharmacokinetics of bambuterol.
Sitar DS. Sitar DS. Clin Pharmacokinet. 1996 Oct;31(4):246-56. doi: 10.2165/00003088-199631040-00002. Clin Pharmacokinet. 1996. PMID: 8896942 Review.
Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma.
Bartow RA, Brogden RN. Bartow RA, et al. Drugs. 1998 Feb;55(2):303-22. doi: 10.2165/00003495-199855020-00016. Drugs. 1998. PMID: 9506248 Review.
Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects.
Dente FL, Bancalari L, Bacci E, Bartoli ML, Carnevali S, Cianchetti S, Di Franco A, Giannini D, Vagaggini B, Testi R, Paggiaro PL. Dente FL, et al. Thorax. 1999 Jul;54(7):622-4. doi: 10.1136/thx.54.7.622. Thorax. 1999. PMID: 10377209 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information